http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103230366-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate | 2013-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103230366-B |
| titleOfInvention | Novel slow-release breast perfusion agent for preventing cow subclinical mastitis and preparation method thereof |
| abstract | The invention provides a novel slow-release breast perfusion agent for preventing cow subclinical mastitis and a preparation method thereof. 100g of the novel slow-release breast perfusion agent comprises 1 to 5g of cephapirin benzathine, 0.5 to 8g of polyethylene glycol-400, Tween materials or propylene glycol, 0.5 to 8g of fatty alcohol-polyoxyethylene ether, cyclomethylene glyceryl ether, glyceryl triacetate or poloxamer, 0.02 to 0.05g of vitamin E, 0.05 to 0.1g of benzyl alcohol, and the balance soybean oil for injection, liquid paraffin or median-chain triglyceride. The invention also provides a preparation method of the novel slow-release breast perfusion agent. The novel slow-release breast perfusion agent is suspended colloid, can be released slowly, has low administration frequency, can prevent cow subclinical mastitis in a mild shortage stage, and does not produce residues in milk in a lactation stage. Compared with foreign like products, the suspended colloid has better stability. |
| priorityDate | 2013-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.